China mRNA Player Abogen Gets $300m More As Country Eyes Omicron Threat
Will $1bn Lead To First Domestic mRNA Vaccine?
From inactivated virus-based to mRNA platforms, the race is on in China to develop vaccines to fight the latest omicron variant, with substantial new funding pouring into one young mRNA company.
